tirzepatide and Compounded to Treat Diabetes Tirzepatide, a New Era of

In June 2021, Wegovy, was FDA approved for weight loss

1 GLP-1 receptor agonists have also been shown to have cardioprotective effects and have been suggested to also have renoprotective effects, 2 though there are few published data in patients with CKD

AOD-9604 is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications

GLP-1s have also been shown to reduce systemic inflammation in parts of the body

But now that the medication is back in supply, the FDA has limited the production of compounded semaglutide

This liposomal delivery system encapsulates glutathione in a protective bubble, making it an armoured vehicle that travels the digestive battlefield without getting harmed